Temasek Holdings (Private) LTD Bio N Tech Se Transaction History
Temasek Holdings (Private) LTD
- $21.4 Billion
- Q2 2024
A detailed history of Temasek Holdings (Private) LTD transactions in Bio N Tech Se stock. As of the latest transaction made, Temasek Holdings (Private) LTD holds 1,807,232 shares of BNTX stock, worth $214 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
1,807,232
Previous 3,430,250
47.31%
Holding current value
$214 Million
Previous $316 Million
54.11%
% of portfolio
0.68%
Previous 1.76%
Shares
7 transactions
Others Institutions Holding BNTX
# of Institutions
328Shares Held
40.6MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$979 Million0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$567 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$518 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$346 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$224 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.7B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...